Q32 Bio Inc. Common Stock QTTB
$8.27
-13.22%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $36.50
- Implied Upside
- +341.4%
- Price Target Range
- $14.00 – $66.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-28 | JefferiesMaury Raycroft |
Initiates coverage on | Buy | $29 |
| 2026-08-24 | Morgan StanleyJudah Frommer |
Initiates coverage on | Overweight | $34 |
| 2026-07-28 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $13 → $36 |
| 2026-07-13 | OppenheimerJay Olson |
Maintains | Outperform | $20 → $40 |
| 2026-07-13 | Wells FargoDerek Archila |
Upgrades | Equal-weight → Overweight | $66 |
| 2026-05-22 | MizuhoJoseph Catanzaro |
Initiates coverage on | Outperform | $14 |
| 2026-05-18 | Cantor Fitzgerald |
Initiates coverage on | Overweight | — |
| 2026-05-05 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $13 |
| 2026-02-25 | HC Wainwright & Co.Joseph Pantginis |
Initiates coverage on | Buy | $13 |
| 2025-03-12 | Wells FargoDerek Archila |
Maintains | Equal-weight | $16 → $15 |
| 2025-02-11 | BMO CapitalEtzer Darout |
Downgrades | Outperform → Market perform | $22 → $3 |
| 2025-02-11 | Piper SandlerChristopher Raymond |
Downgrades | Overweight → Neutral | $20 → $4 |
| 2024-12-12 | BMO CapitalEtzer Darout |
Maintains | Outperform | $64 → $22 |
| 2024-12-12 | GuggenheimYatin Suneja |
Downgrades | Buy → Neutral | — |
| 2024-12-11 | OppenheimerJay Olson |
Maintains | Outperform | $80 → $20 |
| 2024-12-11 | Piper SandlerChristopher Raymond |
Maintains | Overweight | $85 → $20 |
| 2024-12-11 | Wells FargoDerek Archila |
Downgrades | Overweight → Equal-weight | $95 → $16 |
| 2024-12-11 | Leerink PartnersThomas Smith |
Downgrades | Outperform → Market perform | $68 → $9 |
| 2024-12-11 | Raymond JamesSteven Seedhouse |
Downgrades | Strong buy → Outperform | $90 → $22 |
| 2024-12-06 | BMO CapitalEtzer Darout |
Initiates coverage on | Outperform | $64 |
| 2024-10-24 | Raymond JamesSteven Seedhouse |
Initiates coverage on | Strong buy | $90 |
| 2024-09-11 | Wells FargoSarah Akers |
Initiates coverage on | Overweight | $95 |
| 2024-06-17 | GuggenheimYatin Suneja |
Initiates coverage on | Buy | $100 |
| 2024-05-21 | Leerink PartnersThomas Smith |
Initiates coverage on | Outperform | $54 |
| 2024-04-11 | OppenheimerJay Olson |
Initiates coverage on | Outperform | $50 |
| 2024-04-02 | Piper SandlerChristopher Raymond |
Initiates coverage on | Overweight | $45 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $8.27
- Market Cap
- $246.19 million
- 52-Week Range
- $1.62 – $23.57
- Average Volume
- 772K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.